Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
PSP Enrolment Form Review Requirements
-
We’re hoping to clarify whether PSP enrolment forms always require PAAB review. Is there any situation where these forms wouldn’t require review?
Since enrolment forms typically don’t include claims, we’re wondering if the content could be simplified or limited in a way that might exempt them from review.
We’d greatly appreciate your guidance to ensure we’re approaching this correctly.
-
Hello @medwriter
Exemption criteria can be found in PAAB Code section 1.5. There are many factors that can render a PSP enrolment form subject to advertising regulations. Some examples include specific copy on the enrolment form, mention of therapeutic use, distribution, linked content (all forms of linkage), PSP program name, imagery, etc. This is not an exhaustive list.
In general, if it is going to a patient through an HCP and it is a company created/sponsored PSP, it is subject to review. The activity is promoting enrolment in a company sponsored program for which they have a vested interest. See Code Section 7.4. The review process ensures no unintentional promotions or messaging outside the regulations.
-
@jennifer-carroll Thank you kindly for the clarification - this is helpful.
